Mucus Relief Extended Release Tablet
Product Images NDC 41520-731

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief Extended Release (NDC 41520-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Care One (american Sales Company), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin 600 mg (Mucus Relief 600 mgextended Release Caplets 1)

Guaifenesin 600 mg (Mucus Relief 600 mgextended Release Caplets 1)
This is a drug fact label for an extended-release tablet containing Guaifenesin 600mg used for loosening phlegm and relieving chest congestion. It is not to be used for children below 12 years, and people with persistent coughs due to smoking, chronic bronchitis, or emphysema should ask a doctor before use. Overdose, rash, or persistent headache during the use of the drug may be signs of severe illness, and it should not exceed the dosage of more than 4 tablets per day. The inactive ingredients are colloid silicon dioxide, blue aluminum lake, talc, and magnesium stearate, among others. It is distributed by FoodHold USA LLC, and it is compared to the active ingredient in Mucinex.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.